欢迎访问《岭南现代临床外科》官方网站,今天是

岭南现代临床外科 ›› 2016, Vol. 16 ›› Issue (06): 642-646.DOI: 10.3969/j.issn.1009?976X.2016.06.002

• 述评 • 上一篇    下一篇

甲状腺乳头状癌相关基因的研究进展

赵竞 刘生   

  1. 中山大学孙逸仙纪念医院
  • 通讯作者: 刘生

Advances in the study of genes associated with papillary thyroid carcinoma

HAO Jing,LIU Sheng.   

  • Online:2016-12-20 Published:2016-12-20
  • Contact: LIU Sheng.

摘要:

【摘 要】 甲状腺癌是最常见的内分泌器官的恶性肿瘤。其中甲状腺癌乳头状癌大约占90%。虽然大部分甲状腺乳头状癌的诊断和治疗没有很大的困难,但是部分仍存在挑战。随着对甲状腺乳头状癌的基因和生物学特征的了解以及新的靶向治疗的发展,对其的诊断和治疗有了进一步的发展。本文就最近有关甲状腺乳头状癌的基因的相关进展以及它们对肿瘤进展的重要意义进行系统综述。

关键词: 基因, 靶向治疗, 诊断, 甲状腺乳头状癌

Abstract:

【Abstract】 Thyroid carcinoma is the most common malignant tumor of endocrine organs. Papillary thyroid carcinoma accounts for approximately 90% of thyroid cancers. While most tumors can be diag-nosed and treated without much difficulty, a few tumors, sometimes still pose some diagnostic or thera-peutic challenges. Advances in the understanding of the genetic and biologic characteristics of thyroid papillary cancer, coupled with the development of new molecular targeted therapeutics, have led to the improved diagnosis and treatment of patients with this cancer. In the current review, we summarize re-cent research on genetic characteristics of the thyroid papillary cancer and their importance for the devel-opment of tumor.

Key words: Papillary thyroid carcinoma, Targeted therapy, Gene, Diagnosis

中图分类号: